| Compound | HGH Fragment 176-191 |
|---|---|
| Category | Lipolytic HGH fragment |
| Class | Growth Hormone and Growth Factors |
| Evidence tier | Minimal evidence |
| WADA status | Not individually listed; verify current status if subject to testing |
| Sold on this site | No — this is a reference database |
Overview
HGH Fragment 176-191 is catalogued here as a lipolytic hgh fragment and graded at the "Minimal evidence" evidence tier. There is little or no formal study of this compound. Claims rest on anecdote, theory, or very early-stage work; risk data are absent by definition.
A synthetic fragment of the growth hormone molecule studied for isolated fat-metabolism effects in animal work. Human evidence is essentially absent.
Mechanism of Action
The 176-191 region of GH is associated with lipolytic activity in early pharmacology research; the fragment is hypothesized to retain fat-mobilizing effects without growth-promoting or diabetogenic actions.
Research and Evidence
A handful of animal studies from decades ago; no controlled human trials. The related modified peptide AOD-9604 failed in obesity trials (see its entry).
Safety and Side Effects
No human safety database; unregulated product quality is the immediate practical risk.
Frequently Asked Questions
What is the evidence tier of HGH Fragment 176-191?
HGH Fragment 176-191 is graded "Minimal evidence" on this site. There is little or no formal study of this compound. Claims rest on anecdote, theory, or very early-stage work; risk data are absent by definition.
Is HGH Fragment 176-191 an approved medicine?
No. Minimal evidence means the compound has not reached universal regulatory approval; the tier description above explains exactly what level of evidence exists.
Where can I read the primary studies for HGH Fragment 176-191?
The references section at the end of this entry links the key primary sources — regulator labels, trial registrations, and peer-reviewed papers. Our "How to Read a Peptide Study" guide explains how to evaluate them.
References
- ClinicalTrials.gov — search for HGH fragment studies. [source]
Evidence tier: Minimal evidence · Last reviewed: 2026-09-05 · Sources cited below.